Cancer News

Health Diaries > Health News > Cancer News > September 2005

September 28, 2005

Pomegranate Juice for Prostate Cancer

Pomegranate juice, a deep red juice becoming popular as a health drink, works against prostate cancer cells in lab dishes and in mice, U.S. researchers reported Tuesday. (MSNBC)

Posted by news editor at 7:41 AM | Comments (0)

September 16, 2005

Pancreatic Cancer and Vegetables in Diet

Elizabeth A. Holly, PhD, professor of epidemiology and biostatistics at the University of California, San Francisco, researched more than 2,200 San Francisco Bay residents, including 532 pancreatic cancer patients. Those who ate six or more servings of vegetables every day got pancreatic cancer half as often as those who ate less than three servings a day. (WebMD)

Posted by news editor at 4:08 PM | Comments (0)

Broccoli May Fight Lung Cancer

New research shows that a family of compounds found in broccoli and other cruciferous vegetables -- like cauliflower and watercress -- may stop the spread of lung cancer and lead to new treatments for the deadly disease. (

Posted by news editor at 4:01 PM | Comments (0)

September 6, 2005

Gilligan's Island Star Bob Denver Dies

Bob Denver, the actor who played goofy island castaway Gilligan in the 1960s television show "Gilligan's Island," has died of complications from cancer treatments, his agent Mike Eisenstadt said on Tuesday. (Reuters)

Posted by news editor at 1:00 PM | Comments (0)

September 3, 2005

Chief Justice Rehnquist Dies of Thyroid Cancer

Chief Justice William H. Rehnquist died Saturday at his home in Arlington, Virginia after battling thyroid cancer for almost a year. (

Posted by news editor at 8:17 PM | Comments (0)

September 1, 2005

Naproxen and Vitamin D Stop Prostate Cancer Cells

A combination of vitamin D and an over-the-counter painkiller halts the growth of prostate cancer cells, researchers at Stanford University report. (

Posted by news editor at 8:59 AM | Comments (0)

Drug Weakens Cancer Cells

Tumors in cancer-ridden mice shrank by 90 percent after treatment with the drug, researchers report in a study to be released Tuesday. The compound, called OGT2378, appears to block the ability of cancer cells to grow by manipulating the host's immune system. (

Posted by news editor at 8:45 AM | Comments (0)